Methylphenidate Hydrochloride Tablet, Extended Release
Product Images NDC 72162-2395

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 72162-2395). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl721622395)

Label for Methylphenidate Hydrochloride Extended-Release Tablets, USP 27 mg. The label includes the NDC 72162-2395-1 and indicates a package size of 100 tablets. It shows the labeler Bryant Ranch Prepack and manufacturer Kremers Urban Pharmaceuticals Inc. Instructions include storage conditions, dosage guidance, and a reminder to keep out of reach of children. The label also features QR codes for package insert and medication guide.*

FDA Label Image

Chemical Structure (Methylphenidate Hydrochloride Extended Release Tab 1)

Chemical structure of Methylphenidate Hydrochloride showing its molecular composition, including a phenyl group, ester moiety, and piperidine ring with a hydrochloride salt.*

FDA Label Image

Figure 1 (Methylphenidate Hydrochloride Extended Release Tab 2)

A line graph showing mean plasma concentration (ng/mL) of methylphenidate over time (hours). Two dosing regimens are compared: 18 mg once daily and 5 mg three times daily. The graph illustrates concentration changes up to 32 hours post-dose.*

FDA Label Image

Figure 2 (Methylphenidate Hydrochloride Extended Release Tab 3)

A bar graph displaying the Inattention/Overactivity Scale scores comparing Methylphenidate Hydrochloride once daily versus placebo across three studies labeled Study 1, Study 2, and Study 3 (Week 1). The y-axis shows the scale from 0 to 15 with higher scores indicating more symptoms. Black bars represent Methylphenidate HCl, and white bars represent placebo controls.*

FDA Label Image

Figure 3 (Methylphenidate Hydrochloride Extended Release Tab 4)

A line graph depicting the Combined Attention Subscale over 12 hours post initial dose, comparing Methylphenidate Hydrochloride once daily and placebo. The y-axis ranges from 0.0 (More Attentive) to 3.0 (Less Attentive), and the x-axis shows hours from 1 to 12. Mean and standard error are indicated, with two groups represented by separate lines and markers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.